145 related articles for article (PubMed ID: 30254957)
1. Hysteroscopic Management of Retained Products of Conception.
Lin YH; Cheng YY; Ding DC
Gynecol Minim Invasive Ther; 2018; 7(3):133-135. PubMed ID: 30254957
[TBL] [Abstract][Full Text] [Related]
2. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report.
Alonso L; Nieto L; Carugno J
J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors?
Barel O; Krakov A; Pansky M; Vaknin Z; Halperin R; Smorgick N
Fertil Steril; 2015 Mar; 103(3):775-9. PubMed ID: 25527235
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopy and Retained Products of Conception: An Update.
Foreste V; Gallo A; Manzi A; Riccardi C; Carugno J; Sardo ADS
Gynecol Minim Invasive Ther; 2021; 10(4):203-209. PubMed ID: 34909376
[TBL] [Abstract][Full Text] [Related]
5. Office hysteroscopy in removing retained products of conception - a highly successful approach with minimal complications.
Jakopič Maček K; Blaganje M; Kenda Šuster N; Drusany Starič K; Kobal B
J Obstet Gynaecol; 2020 Nov; 40(8):1122-1126. PubMed ID: 31793362
[TBL] [Abstract][Full Text] [Related]
6. Hysteroscopic resection for management of early pregnancy loss: a case report and literature review.
Young S; Miller CE
F S Rep; 2022 Jun; 3(2):163-167. PubMed ID: 35789723
[TBL] [Abstract][Full Text] [Related]
7. A Case of Placenta Accreta Infection Managed by Hysterectomy After Treatment for Retained Products of Conception With Uterine Artery Embolization and Hysteroscopy.
Fukuoka H; Sato H; Okabe M; Togashi K; Oyama N
Cureus; 2023 Apr; 15(4):e37854. PubMed ID: 37223160
[TBL] [Abstract][Full Text] [Related]
8. Hysteroscopic removal of retained products of conception following first trimester medical abortion.
Smorgick N; Levinsohn-Tavor O; Ben-Ami I; Maymon R; Pansky M; Vaknin Z
Gynecol Minim Invasive Ther; 2017; 6(4):183-185. PubMed ID: 30254910
[TBL] [Abstract][Full Text] [Related]
9. Management of Hypervascular Retained Products of Conception With Massive Bleeding.
Shimada T; Wakimoto Y; Kamihigashi M; Tanaka H; Shibahara H
Cureus; 2023 Sep; 15(9):e45952. PubMed ID: 37885542
[TBL] [Abstract][Full Text] [Related]
10. See-and-treat in-office hysteroscopy versus operative hysteroscopy for the treatment of retained products of conception: A retrospective study.
Raz N; Sigal E; Gonzalez Arjona F; Calidona C; Garzon S; Uccella S; Laganà AS; Haimovich S
J Obstet Gynaecol Res; 2022 Sep; 48(9):2459-2465. PubMed ID: 35698805
[TBL] [Abstract][Full Text] [Related]
11. Hysteroscopic management of retained products of conception: A systematic review.
Taylor C; Ellett L; Hiscock R; Mooney S
Aust N Z J Obstet Gynaecol; 2022 Feb; 62(1):22-32. PubMed ID: 34751942
[TBL] [Abstract][Full Text] [Related]
12. Retained Products of Conception (RPOC): Diagnosis, Complication & Management.
Chawla S; Sharma R
J Obstet Gynaecol India; 2023 Oct; 73(5):374-380. PubMed ID: 37916054
[TBL] [Abstract][Full Text] [Related]
13. Two-step hysteroscopy for management of morbidly adherent retained products of conception.
Smorgick N; Rabinovitch I; Levinsohn-Tavor O; Maymon R; Vaknin Z; Pansky M
Arch Gynecol Obstet; 2019 Sep; 300(3):669-674. PubMed ID: 31321494
[TBL] [Abstract][Full Text] [Related]
14. Pregnancies Following Hysteroscopic Removal of Retained Products of Conception after Delivery Versus Abortion.
Ganer Herman H; Kogan Z; Tairy D; Ben Zvi M; Kerner R; Ginath S; Bar J; Sagiv R
Gynecol Obstet Invest; 2018; 83(6):586-592. PubMed ID: 29945122
[TBL] [Abstract][Full Text] [Related]
15. Conservative and timely treatment in retained products of conception: a case report of placenta accreta ritention.
Guarino A; Di Benedetto L; Assorgi C; Rocca A; Caserta D
Int J Clin Exp Pathol; 2015; 8(10):13625-9. PubMed ID: 26722586
[TBL] [Abstract][Full Text] [Related]
16. Hysteroscopic management of retained products of conception: meta-analysis and literature review.
Smorgick N; Barel O; Fuchs N; Ben-Ami I; Pansky M; Vaknin Z
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():19-22. PubMed ID: 24332096
[TBL] [Abstract][Full Text] [Related]
17. Hysteroscopic resection with temporary balloon catheter occlusion of bilateral internal iliac arteries for managing retained products of conception after spontaneous abortion: Two cases report.
Ono Y; Sakurai Y; Ota H; Tanaka K; Okada H; Tagaya H; Fukushi Y; Yoshino O; Wada S
J Obstet Gynaecol Res; 2023 Feb; 49(2):753-758. PubMed ID: 36305385
[TBL] [Abstract][Full Text] [Related]
18. A novel method for office aspiration curettage in cases of retained products of conception: A randomized controlled trial.
Pomeranz M; Goren Gepstein N; Ovadia M; Klein Z; Daykan Y; Schonman R; Arbib N
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2076-2081. PubMed ID: 34467531
[TBL] [Abstract][Full Text] [Related]
19. Operative hysteroscopy for retained products of conception: Efficacy and subsequent fertility.
Capmas P; Lobersztajn A; Duminil L; Barral T; Pourcelot AG; Fernandez H
J Gynecol Obstet Hum Reprod; 2019 Mar; 48(3):151-154. PubMed ID: 30553048
[TBL] [Abstract][Full Text] [Related]
20. Role of clinical and ultrasound findings in the diagnosis of retained products of conception.
Abbasi S; Jamal A; Eslamian L; Marsousi V
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):704-7. PubMed ID: 18792059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]